Baxter in advanced talks to acquire Hill-Rom for about $10 billion

  • Baxter International (NYSE:BAX) is in advanced discussions to buy Hill-Rom Holdings (NYSE:HRC) in a deal that could value the medical equipment maker at around $10B, The Wall Street Journal reported, citing people familiar with the matter.
  • The agreement to acquire Hill-Rom (HRC), valuing it at about $150 per share, could be reached as early as midweek, assuming the talks would continue, according to sources.
  • The news of the latest bid comes after Chicago-based Hill-Rom (HRC) rejected an earlier offer made by Baxter International (BAX) in July to acquire the company for $144 per share.

    Over the current book year the total revenu from the company based in Deerfield will be 12.61 billion USD (consensus estimates). This is slightly more than 2021's revenue of 11.67 billion USD.

    Historical revenues and results Baxter International plus estimates 2021

    financiële analyse

    The analysts expect for 2021 a net profit of 1.8 billion USD. Most of the analysts anticipate on a profit per share of 3.52 USD. The price/earnings-ratio therefore equals 23.03.

    Per share the analysts anticipate on a dividend of 1.05 USD per share. The dividend yield is then 1.3 percent. The average dividend yield of the pharmaceutical companies is a poor 1.37 percent.

    Baxter International 's market capitalization is based on the number of outstanding shares around 41.03 billion USD. -2

    At 17.57 the stock trades 1.94 percent higher at 81.06 USD.

    Historical stock prices Baxter International

    financial analysis baxterinternational

    ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
    news@valuespectrum.com

    Copyright analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.

    • Sector news
    Intuitive Surgical's sales on record level according analysts' estimates
    KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
    Analysts: L'Oreal on steam for record sales
    Analysts count on revenue increase Ontex
    Analysts: this year best year ever for McKesson
    ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
    ONWARD® TO PARTICIPATE IN BASEL HEALTHTECH CONFERENCE 2024
    National news
    Analysts expect record sales Lockheed Martin
    Analysts: more sales Halliburton
    Fiserv's sales on record level according analysts' estimates
    Intuitive Surgical's sales on record level according analysts' estimates
    Analysts are counting on record year NetFlix
    Analysts expect record sales CSX
    Analysts expect sales decline Carmax
    Press news
    Schweizer Electronic AG: Expansion of the Executive Board – Appointment of Mr. Thomas Gottwald as new member of the Executive Board
    q.beyond supports introduction of SAP S/4HANA at Neue Westfälische with its applications expertise
    NorCom wins tender from the Federal Employment Agency for Business Intelligence Platform
    HHLA acquires interest in Austrian intermodal service provider Roland Spedition GmbH
    audius publishes its annual report for 2023 and proposes a dividend of 35 cents per share (news with additional features)
    OHB SE: Consolidated financial statements 2023
    Mayr-Melnhof Karton AG: MM reports first quarter 2024 results
    Logoanalist
    Returns European stocks
    Crypto currencies information
    About us Network Partners
    Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2024 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo